Lenalidomide

Back to search

Molecule Structure

Scientific Name

Lenalidomide

Description of the Drug

Lenalidomide is a thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00480

Brand Name(s)

Revlimid

Company Owner(s)

Arrow International Ltd, Celgene Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
CRL4(CRBN) E3 ubiquitin ligase PROTEIN COMPLEX INHIBITOR CHEMBL3833061

Unichem Links

SureChEMBL SCHEMBL32978
PharmGKB PA162363968
Human Metabolome Database HMDB0014623
DrugBank DB00480
PubChem: Thomson Pharma 14847985
PubChem 216326
Mcule MCULE-9771679074
LINCS LSM-6187
Nikkaji J1.121.689G
BindingDB 65454
EPA CompTox Dashboard DTXSID8046664
DrugCentral 3317
ChemicalBook CB3855432
Guide to Pharmacology 7331
GSRS 8bb063b4-594a-40a4-a344-1233a3d834d8
rxnorm REVLIMID LENALIDOMIDE
PubChem: Drugs of the Future 12015317
ChEBI 63791